Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Toxicology,General Neuroscience
Reference24 articles.
1. Biaggioni I (1992) Contrasting excitatory and inhibitory effects of adenosine in blood pressure regulation. Hypertension 20(4):457–465
2. Boison D (2012) Adenosine augmentation therapy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (eds) Jasper’s basic mechanisms of the epilepsies, 4th edn, Bethesda
3. Bueters TJ, Groen B, Danhof M, AP IJ, Van Helden HP (2002) Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication. Arch Toxicol 76(11):650–656.
https://doi.org/10.1007/s00204-002-0395-x
4. Bueters TJ, Joosen MJ, van Helden HP, Ijzerman AP, Danhof M (2003) Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin. J Pharmacol Exp Ther 304(3):1307–1313.
https://doi.org/10.1124/jpet.102.044644
5. Compton JR (2004) Adenosine receptor agonist Pd 81,723 protects against seizure/status epilepticus and neuropathology following organophosphate exposure. Walter reed army inst of research silver spring md published by wrair and available through dtic
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献